Consumer Non-Durables
Ajinomoto Co., Inc.
In the news
- Itochu and Keyence lead Japan's return to the office Jun 19, 2020
- Mizuho investors demand transparency on coal exposure Jun 18, 2020
- A more flexible Japan Inc returns to the office May 29, 2020
- Too close? Japanese companies reluctant to change auditors Jan 25, 2020
- Early retirement up in Japan as companies seek younger staff Dec 7, 2019 See more articles on Ajinomoto Co., Inc.
Business Summary
Ajinomoto Co., Inc. engages in the manufacture, distribution, and sale of food products, amino acids, and pharmaceuticals. It operates through the following segments: Domestic Food Products, Overseas Food Products, Life Support, Healthcare and Others. The Domestic Food Products segment includes seasonings and processed foods, and frozen foods. The Overseas Food Products segment provides consumer foods, which include flavor seasonings and instant noodles; and umami seasonings for processed food manufacturers. The Life Support segment offers feed-use amino acids, amino acids for pharmaceuticals and foods, sweeteners, pharmaceutical fine chemicals, and specialty chemicals. The Healthcare segment handles medical foods and pharmaceuticals. The Others segment covers the packaging materials business, healthcare business, partnership business, logistics, and other services. The company was founded by Saburosuke Suzuki II on May 20, 1909 and is headquartered in Tokyo, Japan.
Financial Highlights
| Mar 2020 | JPY | USD |
| Revenue | 1,100.03B | 10,117.55M |
| Gross Profit | 384,968M | 3,540.72M |
| Operating income | 101,591M | 934.37M |
| Income before tax | 48,795M | 448.78M |
| Net income | 18,643M | 171.46M |
| EBITDA | 163,051M | 1,499.65M |
| Diluted EPS | 34.34 | 0.31 |
| Dividends Per Share | 32 | 0.29 |
| Total Assets | 1,353.61B | 12,538.70M |
| Total liabilities | 761,542M | 7,054.25M |
| Total equity | 538,975M | 4,992.58M |
| Operating cash flow | 114,856M | 1,056.38M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
| Revenue | 1,149.42B | 1,091.19B | 1,114.78B | 1,114.30B | 1,100.03B |
| Gross Profit | 377,368M | 374,412M | 381,827M | 381,444M | 384,968M |
| Operating income | 95,816M | 87,130M | 91,084M | 93,371M | 101,591M |
| Income before tax | 98,778M | 86,684M | 80,819M | 54,698M | 48,795M |
| Net income | 68,504M | 53,065M | 57,533M | 27,509M | 18,643M |
| EBITDA | 147,680M | 133,782M | 142,867M | 145,856M | 163,051M |
| Diluted EPS | 121.23 | 92.81 | 105.75 | 53.61 | 34.34 |
| Dividends Per Share | 28 | 30 | 32 | 32 | 32 |
| Total Assets | 1,273.89B | 1,350.10B | 1,426.23B | 1,393.86B | 1,353.61B |
| Total liabilities | 593,161M | 659,428M | 705,612M | 707,904M | 761,542M |
| Total equity | 609,486M | 616,315M | 640,833M | 610,543M | 538,975M |
| Operating cash flow | 129,311M | 108,907M | 126,655M | 123,256M | 114,856M |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
| Revenue | 9,571.83M | 10,076.83M | 10,058.28M | 10,048.34M | 10,117.55M |
| Gross Profit | 3,142.52M | 3,457.57M | 3,445.08M | 3,439.69M | 3,540.72M |
| Operating income | 797.90M | 804.61M | 821.81M | 841.97M | 934.37M |
| Income before tax | 822.57M | 800.49M | 729.19M | 493.24M | 448.78M |
| Net income | 570.46M | 490.03M | 519.09M | 248.06M | 171.46M |
| EBITDA | 1,229.80M | 1,235.43M | 1,289.03M | 1,315.26M | 1,499.65M |
| Diluted EPS | 1.00 | 0.85 | 0.95 | 0.48 | 0.31 |
| Dividends Per Share | 0.23 | 0.27 | 0.28 | 0.28 | 0.29 |
| Total Assets | 11,334.07M | 12,116.17M | 13,410.71M | 12,593.11M | 12,538.70M |
| Total liabilities | 5,277.46M | 5,917.86M | 6,634.80M | 6,395.66M | 7,054.25M |
| Total equity | 5,422.71M | 5,530.96M | 6,025.69M | 5,516.04M | 4,992.58M |
| Operating cash flow | 1,076.83M | 1,005.72M | 1,142.76M | 1,111.46M | 1,056.38M |
Valuation Measures
| Mar 2020 | |
| PER | 58.50 |
| ROA | 1.35% |
| ROE | 3.24% |
| Operating margin | 9.23% |
| Profit margin | 1.69% |
Key executives
- President, CEO & Representative Director: Takaaki Nishii
- Head-Finance, Accounting & Planning Group: Eiichi Mizutani
- General Manager-Technology Development Center: Masaki Kashihara
- GM-Quality Assurance, Research & Planning: Hiroyuki Kojima
- Representative Director & Executive Vice President: Hiroshi Fukushi
Shareholders
- Nomura Asset Management Co., Ltd. (5.2%)
- Dai-ichi Life Holdings, Inc. (4.7%)
- Nippon Life Insurance Co. (4.6%)
- Mitsubishi UFJ Financial Group, Inc. (4.1%)
- Asset Management One Co., Ltd. (3.4%)
- Nikko Asset Management Co., Ltd. (2.8%)
- The Vanguard Group, Inc. (2.6%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.3%)
- Meiji Yasuda Life Insurance Co. (2.2%)
- Daiwa Asset Management Co. Ltd. (2.0%)
Contact Details
- Website:http://www.ajinomoto.co.jp
- Address: 1-15-1 Kyobashi, Chuo-Ku, Tokyo, 104-8315, Japan
- Phone: +81.3.5250.8111
Related Companies
- AB Logistics (Thailand) Co., Ltd.
- Ajinomoto Bio-Pharma Services
- Ajinomoto Genexine Co. Ltd.
- Dadelos Agrosolutions SL
- Ajinomoto Foods North America, Inc.
- Ajinomoto Board Incentive Plan
- Delica Ace Corp.
- Ajinomoto Bakery Co., Ltd.
- Orgen Gida Sanayi Ve Ticaret AS
- Ace Pack (Thailand) Co. Ltd.
- Althea SARL
- Ajinomoto Phlippines Global Food, Inc.
- Ajinomoto SEA Regional Headquarters Co. Ltd.
- Si Ayutthaya Real Estate Co. Ltd.
- Amoy North America, Inc.
- Shenzhen Amoy Foods Co. Ltd.
- FD Green (Thailand) Co. Ltd.
- Xiamen Ajinomoto Life Ideal Foods Co. Ltd.
- Shanghai Ajinomoto Food Research & Development Center Co. Ltd.
- Ajinomoto (Cambodia) Co. Ltd.
- Ajinomoto Istanbul Food Sales Ltd.
- Ajinomoto Frozen Foods (Thailand) Co. Ltd.
- Ajinomoto Animal Nutrition (Singapore) Pte Ltd.
- Lianyungang Ajinomoto Frozen Foods Co. Ltd.
- Lianyungang Ajinomoto Ruyi Foods Co. Ltd.
- PT Ajinex International
- Ajinomoto Taiwan, Inc.
- Ajinomoto India Pvt Ltd.
- Ajinomoto de Mexico S de RL de CV
- Henan Ajinomoto Amino Acid Co. Ltd.
Competitors
- Evonik Industries AG
- Star Lake Bioscience Co., Inc. Class A
- MeiHua Holdings Group Co Ltd. Class A
- Daesang Corporation
- CJ CheilJedang Corporation
- Mitsubishi Corporation
- Archer-Daniels-Midland Company
- Fufeng Group Limited
- Vedan International (Holdings) Ltd.
- Global Bio-chem Technology Group Co. Ltd.
- Japan Tobacco Inc.
- Emergent BioSolutions Inc.
- Celanese Corporation
- M. Dias Branco SA Industria e Comercio de Alimentos
- Axcella Health, Inc.
Copyright © 2020 FactSet Research Systems Inc. All rights reserved.
Last Updated on 3 Jul, 2020